Chang Hoon Lee

USPTO Granted Patents = 5 (Patent Applications = 5)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 22)

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

2 out of 624

Korea Research Institute of Chemical Technology

Years Active: 2020-2025

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12339670 - Multi-traffic control method for plurality of robots performing autonomous driving (2025-06-24),

2. 11084824 - Pyrazolopyrimidine derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating cancer, autoimmune disease and brain disease containing the same as an active ingredient (2021-08-10),

3. 11053225 - Pyrimidine derivative compound, optical isomer thereof, or pharmaceutically acceptable salt thereof, and composition for preventing or treating Tyro 3 related disease comprising same as active ingredient (2021-07-06),

4. 10804576 - Electrolyte for lithium-sulfur battery and lithium-sulfur battery comprising same (2020-10-13),

5. 10770754 - Electrolyte for lithium-sulfur battery and lithium-sulfur battery comprising same (2020-09-08),

Title: Chang Hoon Lee: Innovator in Robotics and Pharmaceuticals

Introduction

Chang Hoon Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the fields of robotics and pharmaceuticals, holding a total of 5 patents. His innovative work focuses on enhancing autonomous driving technologies and developing pharmaceutical compositions for serious health conditions.

Latest Patents

One of his latest patents is a multi-traffic control method for a plurality of robots performing autonomous driving. This invention discloses a method for controlling a server that manages the movement schedules of multiple robots. The control method includes receiving occupancy requests for nodes that match scheduled moving routes from the robots. It sets actually occupied and provisionally occupied nodes based on these requests, ensuring that the nodes do not overlap among the robots.

Another significant patent involves pyrazolopyrimidine derivatives, which are used in pharmaceutical compositions for preventing or treating cancer, autoimmune diseases, and brain diseases. This invention highlights a preparation method for these derivatives, which exhibit excellent Bruton's tyrosine kinase inhibition activity, making them effective for treating various serious health conditions.

Career Highlights

Chang Hoon Lee has worked with notable organizations such as the Korea Research Institute of Chemical Technology and LG Chem, Ltd. His experience in these institutions has contributed to his expertise in both chemical technology and pharmaceutical development.

Collaborations

He has collaborated with esteemed colleagues, including Sung Yun Cho and Jong Yeon Hwang, further enhancing the impact of his inventions through teamwork and shared knowledge.

Conclusion

Chang Hoon Lee's innovative contributions to robotics and pharmaceuticals demonstrate his commitment to advancing technology and improving health outcomes. His work continues to influence these fields significantly.

This text is generated by artificial intelligence and may not be accurate.